PER
Click for more information
1.41% 7.0¢ percheron therapeutics limited

FDA approves Sareptas Srp901 for the whole population

  1. itsagas
    13,147 Posts.
    lightbulb Created with Sketch. 1380
    clock Created with Sketch.
    21/06/24
    08:43
    Post #: 74417963
    Wow!
    It matters not to PER
    Why?

    1) Boys that can access the gene therapy drug will get it
    others will use other therapies..
    2)The cost $3.2 million will be a stumbling block
    3) US clinicians are skeptical re efficacy
    4)Sarepta is yet to make a profit from the other exon skipping drug
    5)Gene therapy has still got a long way to go before it’s widely accepted
    6) All in all PER will continue with its path forward
    Other exon skipping drugs will use combination therapies.. eg Atl1102

    .
    https://finance.yahoo.com/news/sarepta-therapeutics-announces-expanded-us-210200030.html
    PER Price at posting: 8.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MND Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
right-arrow Created with Sketch.
WCN White Cliff wraps up Canadian fieldwork programs – 'visually confirming' a slew of minerals
right-arrow Created with Sketch.
AVH Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
right-arrow Created with Sketch.
LML Lincoln repositions Kookaburra for low-cost graphite delivery
right-arrow Created with Sketch.
KAI Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
right-arrow Created with Sketch.
NEWS Second Christmas for 2024 coming to Kalgoorlie: Diggers & Dealers starts Monday
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.0¢ 		Change
-0.001(1.41%) 		Mkt cap ! $63.10M
Open High Low Value Volume
7.1¢ 7.1¢ 6.9¢ $34.01K 486.5K

Buyers (Bids)

No. Vol. Price($)
2 132919 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 78000 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.